title: Moraxella keratitis.
abstract: Moraxella corneal ulcers are uncommon but may be complicated by marked inflammation and corneal perforation. In a series of eight cases treated over a period of 6 years, despite appropriate antibiotic therapy, descemetoceles and/or perforations developed in four cases, resulting in loss of the eye in two cases. In our series, the final visual acuity was count fingers or less in most patients (six of eight; 75%). Ulcers not only occurred in patients with systemic diseases, including alcoholism and malnutrition, but also in patients with various pre-existing ocular surface diseases. It is important to be aware of the potential of Moraxella ulcers to result in loss of vision and the eye.
authors.affiliation: Cornea Service, Wills Eye Hospital, Philadelphia, Pennsylvania 19107.
authors.forename: S J
authors.initials: SJ
authors.lastname: Marioneaux
authors.forename: E J
authors.initials: EJ
authors.lastname: Cohen
authors.forename: J J
authors.initials: JJ
authors.lastname: Arentsen
authors.forename: P R
authors.initials: PR
authors.lastname: Laibson
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002437:Cefazolin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000382:microbiology* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007634:Keratitis / Q000188:drug therapy / Q000382:microbiology* / Q000503:physiopathology; D015948:Keratoplasty, Penetrating; D008297:Male; D008875:Middle Aged; D009016:Moraxella / Q000187:drug effects; D012086:Reoperation; D012189:Retrospective Studies; D014031:Tobramycin / Q000627:therapeutic use; D014792:Visual Acuity
chemical_list: D002437:Cefazolin; D014031:Tobramycin